Get AI Briefings, Transcripts & Alerts on Local & National Government Meetings — Forever.
Committee issues mixed recommendations on 13 health-related bills; several sent for further work
Loading...
Summary
The House Health, Human Services and Elderly Affairs Committee reviewed 13 bills in a work session and executive session, recommending some for future legislation (including HB554, HB1010, HB1663, HB1693, SB400, SB495) and voting not to recommend others (including HB580, HB608, HB1347, HB1661, HB1706, SB458).
Members of the House Committee on Health, Human Services and Elderly Affairs met in a work session and executive session to consider 13 bills on topics ranging from patient sterilization to psychedelic research and outpatient substance‑use program certification.
The committee recommended several bills for future legislation, including HB554 FN (alternative treatments related to the opioid crisis; motion passed 14–0), HB1010 (expanded midwifery/maternity options; motion passed 8–7), HB1067 (patient access to sterilization—see separate article), HB1663 (medical‑record confidentiality reform; motion passed 11–4), HB1693 (limited clinical trials/therapeutic research with certain psychedelics; committee recommended narrowly tailored future legislation), SB400 (patient access to medical records; motion passed 12–3) and SB495 (certification of certain substance‑use treatment programs, focused on outpatient programs; motion passed 11–4).
Several bills were voted not recommended for future legislation. Not‑recommended votes included HB580 FN (children’s vision screening initiative within Medicaid; final committee vote not to recommend 9–6 after procedural motions), HB608 FN (Bureau of Developmental Services pilot — committee concluded redesign work has progressed; 15–0 not recommended), HB1347 (refugee resettlement administration; 14–1 not recommended), HB1661 (immunization reporting requirements; after an initial failed motion it was ultimately not recommended 8–7), HB1706 (notice prior to circumcision; 13–2 not recommended) and SB458 (dispensing of certain medications; 15–0 not recommended).
The committee’s executive session recorded roll‑call votes on the motions and reflected significant policy debates: privacy and workload concerns on HB1661 and HB1663; scope‑of‑practice and patient choice tensions in HB1010; and consumer protection and program oversight considerations in SB495.
What’s next: for bills the committee recommended, legislative sponsors and counsel will draft refined language for consideration in the next legislative session; for bills not recommended, sponsors and members signaled that some issues may be better handled by study groups, stakeholder working groups, or administrative action rather than the present statutory language.
Votes and formal actions are documented in the committee record and were taken in executive session as described above. The committee adjourned after closing remarks.
